CME Group (NASDAQ:CME) Issues Earnings Results

CME Group (NASDAQ:CME) posted its quarterly earnings data on Wednesday. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.08, FiscalAI reports. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the previous year, the business earned $2.96 EPS. The company’s quarterly revenue was up .8% compared to the same quarter last year.

Here are the key takeaways from CME Group’s conference call:

• CME reported a strong second quarter, with revenue of more than $1.7 billion, adjusted operating margin of 69.5%, and adjusted diluted EPS of $2.99, while returning $1.2 billion to shareholders through dividends and buybacks.
• Trading activity remained robust, as Q2 average daily volume of 29.8 million contracts was the second-highest second quarter in CME history, open interest rose 8% year over year, and July volumes were running 18% ahead of last year.
• Market data revenue set another record at $238 million, extending the company’s streak to 33 consecutive quarters of year-over-year growth and reflecting continued demand for CME’s pricing and data products.
• Management emphasized a broad product innovation pipeline, including 24/7 crypto and gold trading, upcoming single-stock futures, a planned Treasury Link product, and a new Compute Futures market tied to AI/data-center demand.
• Executives spent much of the call arguing that perpetual futures are not a fit for CME’s institutional customer base, saying they create higher cost and risk than CME’s listed futures, while warning that equity perps could pose systemic risk.

CME Group Price Performance

Shares of NASDAQ CME traded down $2.26 during midday trading on Friday, reaching $252.06. 112,897 shares of the company were exchanged, compared to its average volume of 2,758,302. The stock’s 50-day moving average price is $255.00 and its 200-day moving average price is $281.41. The stock has a market cap of $91.34 billion, a P/E ratio of 21.38, a PEG ratio of 3.10 and a beta of 0.25. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group has a one year low of $218.31 and a one year high of $329.16.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Tuesday, June 9th were given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date was Tuesday, June 9th. CME Group’s dividend payout ratio is currently 44.11%.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group reported Q2 adjusted EPS of $2.99 and revenue of about $1.7 billion, both ahead of Wall Street estimates, which helped drive the stock higher. Reuters article
• Positive Sentiment: Management said first-half 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, while market data revenue hit a record $238 million. Quiver Quantitative article
• Positive Sentiment: Strong trading activity also supported sentiment, with average daily volume reaching 29.8 million contracts and June volume up 19% year over year, suggesting healthy demand for CME’s exchange and clearing services. American Banking News article
• Neutral Sentiment: Options activity picked up sharply, with traders buying 8,099 CME call options, a sign of increased speculative interest but not necessarily a fundamental change. American Banking News article
• Neutral Sentiment: Several analysts remained cautious despite the earnings beat, with JPMorgan and Bank of America keeping bearish ratings even as they nudged price targets higher, while UBS reiterated a Hold view. Benzinga article

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target for the company in a report on Thursday, June 18th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and increased their price target for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Piper Sandler lowered their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. JPMorgan Chase & Co. boosted their price target on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a report on Thursday. Finally, Morgan Stanley lifted their price objective on CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday. Eleven analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $291.81.

Insider Activity at CME Group

In other news, Director William R. Shepard acquired 325 shares of the stock in a transaction dated Thursday, June 25th. The stock was bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the purchase, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This represents a 0.12% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On CME Group

A number of institutional investors have recently modified their holdings of the company. Raymond James Financial Inc. boosted its holdings in shares of CME Group by 5.4% during the 4th quarter. Raymond James Financial Inc. now owns 4,319,763 shares of the financial services provider’s stock worth $1,179,858,000 after buying an additional 222,890 shares in the last quarter. FIL Ltd boosted its stake in CME Group by 5.0% during the fourth quarter. FIL Ltd now owns 3,574,469 shares of the financial services provider’s stock worth $976,116,000 after acquiring an additional 170,046 shares in the last quarter. Invesco Ltd. grew its holdings in CME Group by 23.0% in the third quarter. Invesco Ltd. now owns 2,830,323 shares of the financial services provider’s stock worth $764,725,000 after purchasing an additional 528,358 shares during the period. AQR Capital Management LLC raised its holdings in shares of CME Group by 1.7% during the third quarter. AQR Capital Management LLC now owns 2,431,787 shares of the financial services provider’s stock valued at $657,045,000 after purchasing an additional 39,607 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of CME Group by 1.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,148,161 shares of the financial services provider’s stock worth $586,620,000 after purchasing an additional 26,845 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.